Imaging News and Research

RSS

Landauer announces GPS acquisition

Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring services, today announced the completion of two acquisitions in accordance with its long-term strategic priorities.

10 Nov 2009

Alzheimer's disease research draws national attention

Research that is targeting the early diagnosis of Alzheimer disease has drawn national attention to the work of Michael Seidenberg, PhD, a faculty member at Rosalind Franklin University of Medicine and Science.

10 Nov 2009

Labcyte to receive $5.5 million from Hercules Technology Growth Capital

Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed to provide Labcyte, Inc. (www.labcyte.com) $5.5 million in credit facilities.

9 Nov 2009

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Black Diamond Video, Inc. announces that Yale-New Haven Hospital has selected BDV to install their state-of-the-art Integrated Digital Surgical Suites (IDSS) into their neurosurgical suite and gastrointestinal suites in the new Smilow Cancer Center.

9 Nov 2009

Covisint and Carefx partner to market an integrated workflow solution for health information exchange

Addressing the burgeoning demand for health information exchange (HIE) to coordinate and better leverage patient information, two health IT industry leaders - Covisint, a subsidiary of Compuware Corporation, and Carefx - have partnered to market an integrated workflow solution that ties together the full spectrum of care, from physician offices to labs and pharmacies, to multiple information systems within hospitals.

9 Nov 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Covidien, a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

9 Nov 2009

Merge Healthcare signs distribution agreement with PANGAEA Technology

Merge Healthcare, a leading medical imaging solutions provider, today announced that its Merge China business unit has signed a Distribution Agreement with PANGAEA Technology Limited, a distributor of CCD detectors, which are an economical alternative to digital detectors, for DR systems in the Greater China area.

9 Nov 2009

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Caliper Life Sciences, Inc. today reported results for its third quarter ended September 30, 2009. GAAP revenues increased by 4% to $32.2 million, from non-GAAP revenues of $31.0 million in the same period of 2008, which represents GAAP revenue of $34.0 million in the third quarter of 2008 reduced by $3.0 million for the impact of divested product lines.

9 Nov 2009

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has been awarded a new funding commitment for $1.8 million under its contract with the Environmental Protection Agency (EPA) for the EPA's ToxCast screening program.

9 Nov 2009

Toshiba's Aquilion Premium multi-detector CT installed at PinnacleHealth

Leading hospitals require premium diagnostic imaging equipment to image patients faster, with the best possible diagnostic accuracy. PinnacleHealth, a leading health care system in Harrisburg, Pa., has installed Toshiba America Medical Systems, Inc.’s Aquilion® Premium multi-detector CT at its Community Campus to enable them to meet these needs while improving patient care. The Aquilion Premium features 160 detector rows to image up to eight cm of anatomy in a single gantry rotation (as fast as 0.35 seconds).

9 Nov 2009

Chindex International reports fiscal 2010 second-quarter results

Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced results for the second quarter and first half of fiscal 2010, which ended September 30, 2009.

9 Nov 2009

Researchers develop tools to visualize how different cell populations of cells communicate

Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Their study shows how bacteria talk to one another - an understanding that may lead to new therapeutic discoveries for diseases ranging from cancer to diabetes and allergies.

9 Nov 2009

Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Registration is now open for the Society of Interventional Radiology's "Image-guided Interventional Oncology (IO) Therapies" Webinar, which will provide the latest updates on percutaneous and transcatheter treatment of liver tumors, kidney tumor ablation and lung tumor ablation.

7 Nov 2009

Study finds brain changes and severe depression in political detainees experiencing head injury

Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.

7 Nov 2009

PET scanning emerges as an important tool in the evaluation of lung cancer

A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.

7 Nov 2009

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death.

7 Nov 2009

Latest release of Aspyra’s AccessNET PACS to be demonstrated

Aspyra, Inc. today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.

6 Nov 2009

Cellumen's Rat Hepatocyte Early Safety Assessment Panel increases predictivity for human DILI

Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.

6 Nov 2009

Landmark meeting discusses goal of detecting Alzheimer disease before symptoms appear

This past October, 214 researchers from the U.S., Europe, and Australia, as well as representatives of families with aggressive genetic forms of Alzheimer disease (AD), met at Washington University, St. Louis, Missouri, to devote two intense days of talks and discussion to their goal of detecting this disease before symptoms appear. By a growing consensus, defining the "silent" phase of AD has become the field's central challenge if it is to modernize drug testing and lay the groundwork for AD prevention trials.

6 Nov 2009

Future for magnetic nanoparticles appears even brighter

Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade.

6 Nov 2009

Imaging News and Research

Landauer announces GPS acquisition

Alzheimer's disease research draws national attention

Labcyte to receive $5.5 million from Hercules Technology Growth Capital

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Covisint and Carefx partner to market an integrated workflow solution for health information exchange

Covidien contraindicates use of its Optimark gadoversetamide injection

Merge Healthcare signs distribution agreement with PANGAEA Technology

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Caliper Discovery Alliances and Services receives a $1.8M funding commitment for the EPA's ToxCast program

Toshiba's Aquilion Premium multi-detector CT installed at PinnacleHealth

Chindex International reports fiscal 2010 second-quarter results

Researchers develop tools to visualize how different cell populations of cells communicate

Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Study finds brain changes and severe depression in political detainees experiencing head injury

PET scanning emerges as an important tool in the evaluation of lung cancer

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

Latest release of Aspyra’s AccessNET PACS to be demonstrated

Cellumen's Rat Hepatocyte Early Safety Assessment Panel increases predictivity for human DILI

Landmark meeting discusses goal of detecting Alzheimer disease before symptoms appear

Future for magnetic nanoparticles appears even brighter

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News